Recombinant Human UGGT2 Protein，His & SUMO

UGGT2 (UDP-glucose: glycoprotein glucosyltransferase 2) is an essential enzyme involved in the quality control of glycoprotein folding in the endoplasmic reticulum (ER). It plays a critical role in the glycoprotein maturation process by transferring glucose residues to improperly folded glycoproteins, which serves as a signal for their retention in the ER and eventual refolding or degradation through the ER-associated degradation (ERAD) pathway. The study of UGGT2 is particularly relevant given the increasing recognition of the importance of glycosylation in protein function and its implications in various diseases, including cancer and neurodegenerative disorders. Researchers have also shown that UGGT2 is involved in the viral life cycle of several pathogens, affecting their virulence and host immune responses, which highlights its potential as a therapeutic target. With advancements in recombinant DNA technology, scientists are now able to produce UGGT2 as a recombinant protein for structural and functional analyses. This allows for a deeper understanding of its enzymatic mechanisms, substrate specificities, and interactions with other cellular components. The ongoing research into UGGT2 not only enhances our comprehension of protein folding and modification but also paves the way for the development of novel strategies aimed at modulating glycoprotein functions for therapeutic interventions.